Ubiquitin-conjugating enzyme E2 D1 (Ube2D1) mediates lysine-independent ubiquitination of the E3 ubiquitin ligase March-I

被引:30
作者
Lei, Lei [1 ]
Bandola-Simon, Joanna [1 ]
Roche, Paul A. [1 ]
机构
[1] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
MHC CLASS-II; DENDRITIC CELLS; ANTIGEN PRESENTATION; DOWN-REGULATION; PROTEIN; DEGRADATION; UBIQUITYLATION; ACTIVATION; MECHANISMS; RESIDUES;
D O I
10.1074/jbc.RA117.001322
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
March-I is a membrane-bound E3 ubiquitin ligase belonging to the membrane-associated RING-CH (March) family. March-I ubiquitinates and down-regulates the expression of major histocompatibility complex (MHC) class II and cluster of differentiation 86 (CD86) in antigen-presenting cells. March-I expression is regulated both transcriptionally and posttranslationally, and it has been reported that March-I is ubiquitinated and that this ubiquitination contributes to March-I turnover. However, the molecular mechanism regulating March-I ubiquitination and the importance of March-I's E3 ligase activity for March-I ubiquitination are not fully understood. Here we confirmed that, although March-I is ubiquitinated, it is not ubiquitinated on a lysine residue, as a lysine-less March-I variant was ubiquitinated similarly as wildtype March-I. We found that March-I E3 ligase activity is not required for its ubiquitination and does not regulate March-I protein expression, suggesting that March-I does not undergo autoubiquitination. Knocking down ubiquitin- conjugating enzyme E2 D1 (Ube2D1) impaired March-I ubiquitination, increased March-I expression, and enhanced March-I-dependent down-regulation of MHC-II proteins. Taken together, our results suggest that March-I undergoes lysine-independent ubiquitination by an as yet unidentified E3 ubiquitin ligase that, together with Ube2D1, regulates March-I expression.
引用
收藏
页码:3904 / 3912
页数:9
相关论文
共 31 条
[1]   Ubiquitination of CD86 Is a Key Mechanism in Regulating Antigen Presentation by Dendritic Cells [J].
Baravalle, Guenther ;
Park, Hyesuk ;
McSweeney, Megan ;
Ohmura-Hoshino, Mari ;
Matsuki, Yohei ;
Ishido, Satoshi ;
Shin, Jeoung-Sook .
JOURNAL OF IMMUNOLOGY, 2011, 187 (06) :2966-2973
[2]   Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins [J].
Bartee, E ;
Mansouri, M ;
Nerenberg, BTH ;
Gouveia, K ;
Früh, K .
JOURNAL OF VIROLOGY, 2004, 78 (03) :1109-1120
[3]   Identification of a novel motif that affects the conformation and activity of the MARCH1 E3 ubiquitin ligase [J].
Bourgeois-Daigneault, Marie-Claude ;
Thibodeau, Jacques .
JOURNAL OF CELL SCIENCE, 2013, 126 (04) :989-998
[4]   Autoregulation of MARCH1 Expression by Dimerization and Autoubiquitination [J].
Bourgeois-Daigneault, Marie-Claude ;
Thibodeau, Jacques .
JOURNAL OF IMMUNOLOGY, 2012, 188 (10) :4959-4970
[5]   A novel site for ubiquitination: the N-terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation of the protein [J].
Breitschopf, K ;
Bengal, E ;
Ziv, T ;
Admon, A ;
Ciechanover, A .
EMBO JOURNAL, 1998, 17 (20) :5964-5973
[6]   Regulation of Nedd4-2 self-ubiquitination and stability by a PY motif located within its HECT-domain [J].
Bruce, M. Christine ;
Kanelis, Voula ;
Fouladkou, Fatemeh ;
Debonneville, Anne ;
Staub, Olivier ;
Rotin, Daniela .
BIOCHEMICAL JOURNAL, 2008, 415 :155-163
[7]   Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase [J].
Cadwell, K ;
Coscoy, L .
SCIENCE, 2005, 309 (5731) :127-130
[8]  
Callis Judy, 2014, Arabidopsis Book, V12, pe0174, DOI 10.1199/tab.0174
[9]   N-terminal ubiquitination: more protein substrates join in [J].
Ciechanover, A ;
Ben-Saadon, R .
TRENDS IN CELL BIOLOGY, 2004, 14 (03) :103-106
[10]   E3 ubiquitin ligases as regulators of membrane protein trafficking and degradation [J].
d'Azzo, A ;
Bongiovanni, A ;
Nastasi, T .
TRAFFIC, 2005, 6 (06) :429-441